Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 7,000 shares at $0.50 ($3K) on 2022-05-23, disclosed to the SEC on 2022-06-02.
Open-market purchase of $3k EMMA by Chairman and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.49 | 5,000 | $2K | 71.0% |
| 2 | $0.50 | 2,000 | $1K | 29.0% |
| Total | $0.49 avg | 7,000 | $3K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |